Patents Assigned to biOasis Advanced Technologies Inc.
  • Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
    Patent number: 10716862
    Abstract: The present invention provides for compositions and methods for treating, ameliorating or preventing a lysosomal storage disease by administering to a patient suffering front a lysosomal storage disease a P97 conjugated with an enzyme which is capable of transportation into the lysosomes of cells on either sides of the blood brain barrier.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: July 21, 2020
    Assignee: BiOasis Advanced Technologies Inc.
    Inventors: Christopher M. Starr, Todd Zankel
  • Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
    Patent number: 8546319
    Abstract: The present invention provides for compositions and methods for treating, ameliorating or preventing a lysosomal storage disease by administering to a patient suffering from a lysosomal storage disease a P97 conjugated with an enzyme which is capable of transportation into the lysosomes of cells on either sides of the blood brain barrier.
    Type: Grant
    Filed: March 23, 2010
    Date of Patent: October 1, 2013
    Assignee: biOasis Advanced Technologies Inc.
    Inventors: Christopher M. Starr, Todd Zankel